Literature DB >> 16455648

Proteolytic regulation of nuclear factor of activated T (NFAT) c2 cells and NFAT activity by caspase-3.

Wenfang Wu1, Ravi S Misra, Jennifer Q Russell, Richard A Flavell, Mercedes Rincón, Ralph C Budd.   

Abstract

The nuclear factor of activated T (NFAT) cell family of transcription factors is important in regulating the expression of a broad array of genes, including cytokines, T cell surface receptors, and other transcription factors. NFATc1 and NFATc2 are two principal NFAT members that are expressed in peripheral T cells. Levels of NFAT expression in T cells are partly transcriptionally regulated, but less is understood regarding their post-transcriptional control. We show here that NFATc1 and NFATc2 are rapidly degraded in apoptotic T cells. NFATc2 is highly sensitive to cleavage by caspase-3, whereas NFATc1 is only weakly sensitive to caspase-3 or caspase-8. Two potential caspase-3 cleavage sites were identified in the N-terminal transactivation domain. These sites were confirmed by in vitro caspase cleavage assays. Abolition of NFATc2 cleavage by mutation of these two cleavage sites resulted in augmented NFAT transcriptional activity. Furthermore, NFAT activity could be augmented in wild-type effector T cells by inhibition of caspase activity. Of particular interest was that non-apoptotic T cells from cellular FLIP long transgenic (c-FLIP(L)-Tg) mice that manifest elevated caspase activity have greatly reduced levels of NFATc2 protein and NFAT transcriptional activity. Our findings reveal a new post-transcriptional regulation of NFATc2 that operates, not only during apoptosis, but also in non-apoptotic effector T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455648     DOI: 10.1074/jbc.M511759200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

2.  Pivotal Advance: Nonfunctional lung effectors exhibit decreased calcium mobilization associated with reduced expression of ORAI1.

Authors:  Subhashini Arimilli; Sharad K Sharma; Rama Yammani; Sean D Reid; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Leukoc Biol       Date:  2010-01-26       Impact factor: 4.962

3.  Single-nucleotide polymorphism rs2290692 in the 3'UTR of ITPKC associated with susceptibility to Kawasaki disease in a Han Chinese population.

Authors:  Qian Peng; Changhui Chen; Yu Zhang; Hailan He; Qing Wu; Jing Liao; Bo Li; Caidan Luo; Xiaoping Hu; Zhi Zheng; Yuan Yang
Journal:  Pediatr Cardiol       Date:  2012-02-24       Impact factor: 1.655

4.  Reduced myocarditis following Coxsackievirus infection in cellular FLICE inhibitory protein--long form-transgenic mice.

Authors:  Sally Huber; Austin Dohrman; Danielle Sartini; Ralph C Budd
Journal:  Immunology       Date:  2006-09-28       Impact factor: 7.397

Review 5.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

6.  Interferon regulatory factor 2 binding protein 2 is a new NFAT1 partner and represses its transcriptional activity.

Authors:  Flávia R G Carneiro; Renata Ramalho-Oliveira; Giuliana P Mognol; João P B Viola
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

7.  Common variants in CASP3 confer susceptibility to Kawasaki disease.

Authors:  Yoshihiro Onouchi; Kouichi Ozaki; Jane C Buns; Chisato Shimizu; Hiromichi Hamada; Takafumi Honda; Masaru Terai; Akihito Honda; Takashi Takeuchi; Shoichi Shibuta; Tomohiro Suenaga; Hiroyuki Suzuki; Kouji Higashi; Kumi Yasukawa; Yoichi Suzuki; Kumiko Sasago; Yasushi Kemmotsu; Shinichi Takatsuki; Tsutomu Saji; Tetsushi Yoshikawa; Toshiro Nagai; Kunihiro Hamamoto; Fumio Kishi; Kazunobu Ouchi; Yoshitake Sato; Jane W Newburger; Annette L Baker; Stanford T Shulman; Anne H Rowley; Mayumi Yashiro; Yoshikazu Nakamura; Keiko Wakui; Yoshimitsu Fukushima; Akihiro Fujino; Tatsuhiko Tsunoda; Tomisaku Kawasaki; Akira Hata; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Hum Mol Genet       Date:  2010-04-27       Impact factor: 6.150

8.  Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease.

Authors:  Adriana H Tremoulet; Paige Pancoast; Alessandra Franco; Matthew Bujold; Chisato Shimizu; Yoshihiro Onouchi; Alyson Tamamoto; Guliz Erdem; Debra Dodd; Jane C Burns
Journal:  J Pediatr       Date:  2012-04-06       Impact factor: 4.406

9.  Identification of caspase-mediated decay of interferon regulatory factor-3, exploited by a Kaposi sarcoma-associated herpesvirus immunoregulatory protein.

Authors:  Cristina Aresté; Mohamed Mutocheluh; David J Blackbourn
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

10.  c-Flip overexpression affects satellite cell proliferation and promotes skeletal muscle aging.

Authors:  C Giampietri; S Petrungaro; P Coluccia; F Antonangeli; K Giannakakis; T Faraggiana; A Filippini; G Cossu; E Ziparo
Journal:  Cell Death Dis       Date:  2010-04-29       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.